Cargando…
Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection
Coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, in late December 2019. Since then, COVID-19 has spread rapidly worldwide and was declared a global pandemic on 20 March 2020. Cardiovascular complications are rapidly emerging as a major peril in COVID-19 in addition to respirat...
Autores principales: | Rochette, Luc, Ghibu, Steliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348748/ https://www.ncbi.nlm.nih.gov/pubmed/34360751 http://dx.doi.org/10.3390/ijms22157979 |
Ejemplares similares
-
Impact of Alpha-Lipoic Acid Chronic Discontinuous Treatment in Cardiometabolic Disorders and Oxidative Stress Induced by Fructose Intake in Rats
por: Ghibu, Steliana, et al.
Publicado: (2019) -
Protective Effects of a Discontinuous Treatment with Alpha-Lipoic Acid in Obesity-Related Heart Failure with Preserved Ejection Fraction, in Rats
por: Pop, Cristina, et al.
Publicado: (2020) -
Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection
por: Cure, Erkan, et al.
Publicado: (2020) -
Diabetes and Alpha Lipoic Acid
por: Golbidi, Saeid, et al.
Publicado: (2011) -
Therapeutic Potential of Alpha-Lipoic Acid in Viral Infections, including COVID-19
por: Dragomanova, Stela, et al.
Publicado: (2021)